Bluebook
Pharma Services: Drug Development February 2024
2024 - February: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Continuum Clinical was acquired by Spectrum Science a Portfolio Company of Knox Lane
- Headlands Research announced its acquisition of Pharmasite Research
- Health Data Vision, Inc. closed a $65MM Series A Financing, led by Hercules Capital, Inc. (NYSE:HTGC)